Streetbeat News

Regulatory

VGK

The European Central Bank (ECB) has reduced its deposit facility rate from 3.5% to 3.25%. This decision may impact European financial markets and related ETFs.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:18 pm

VGK

The European Central Bank (ECB) has reduced its benchmark refinancing rate from 3.65% to 3.40%. This decision is likely to impact European markets and could influence US-listed ETFs with European exposure.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:16 pm

BABA

JD

PNQI

XNTK

Alibaba and JD.com are easing their rivalry by sharing logistics services in response to economic challenges and regulatory pressures. This collaboration allows merchants on Alibaba's platforms to use JD.com's logistics services, marking a shift towards more open ecosystems. The Chinese government is also considering a significant fiscal stimulus to boost the economy.

Portfolio Pulse from Anusuya Lahiri

October 17, 2024 | 12:13 pm

AREB

American Rebel Holdings, Inc. (NASDAQ:AREB) has regained compliance with NASDAQ's minimum bid price requirement. The company received a formal notice confirming compliance after maintaining a closing bid price of $1.00 or greater for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:07 pm

ASPI

ASP Isotopes Inc. has successfully accelerated the enrichment of Ytterbium-176 using its Quantum Enrichment technology, achieving initial output within six weeks. The company aims for 99.75% enrichment and commercial availability by 2025. Plans for Nickel-64, Lithium-6/7 plants, and HALEU facility authorization are ongoing.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:03 pm

ABBV

The U.S. FDA has approved AbbVie's VYALEV, a 24-hour subcutaneous infusion therapy for advanced Parkinson's disease, marking a significant advancement in treatment options.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:00 pm

PCG

Pacific Gas and Electric (PCG) has issued advanced notifications to customers in specific areas about potential proactive power shutoffs. This measure is in response to forecasted strong northerly winds and dry vegetation conditions, aiming to reduce wildfire risk.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:46 am

THTX

Theratechnologies has announced the study design for the PROMISE-US trial, which will evaluate the long-term efficacy and durability of Ibalizumab in combination with other antiretroviral therapies. This development is significant for the company's future in HIV treatment.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:35 am

PBM

Psyence Biomedical is confident in PsyLabs' progress towards producing GMP certified, nature-derived psychedelic APIs. After exporting psilocybin extract to the UK, PsyLabs is in phase two of development, focusing on upscaling purification for commercial viability and E.U. GMP certification.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:21 am

NTRB

Nutriband has received approval from the Costa Rica Ministry of Health to produce and market its mosquito repellent patch. This development could expand Nutriband's market reach and potentially increase its revenue.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:18 am